跳至主要内容
临床试验/CTRI/2024/06/068660
CTRI/2024/06/068660尚未招募3 期

Effect of prophylactic nebulization of Colistin versus Amikacin on the incidence of ventilator-associated pneumonia in an intensive care unit setting with prevalent multidrug-resistant bacteria: A prospective double-blind randomized placebo-controlled trial. - NI

Department of Anaesthesiology and Critical Care0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients requiring mechanical ventilation for more than 72 hours.

排除标准

  • Grossly purulent sputum or pneumonia on admission; new and persistent infiltrates on chest radiography within 48 hours from admission.
  • Severe chronic obstructive pulmonary disease (COPD) or preexisting lung disease requiring long-term inhalation drug therapy.
  • Long-term therapy with corticosteroids or immunosuppressive drugs, human immunodeficiency virus infection, cancer.
  • Colonization or infection with a strain resistant to colistin and amikacin on admission.
  • Acute kidney injury on the day of inclusion. Patients undergoing renal replacement therapy or for whom a decision had been made to initiate renal replacement therapy can be included whatever the KDIGO stage.
  • Chronic kidney failure.
  • Pregnancy and breastfeeding women.
  • Allergy to colistin or amikacin.
  • Myasthenia gravis.

研究者

发起方
Department of Anaesthesiology and Critical Care

相似试验